12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Epistem, GlaxoSmithKline deal

The companies partnered to research pulmonary fibrosis biomarkers under a three-year deal. EpiStem will...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >